1. Home
  2. OLMA vs NJR Comparison

OLMA vs NJR Comparison

Compare OLMA & NJR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • NJR
  • Stock Information
  • Founded
  • OLMA 2006
  • NJR 1922
  • Country
  • OLMA United States
  • NJR United States
  • Employees
  • OLMA N/A
  • NJR N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • NJR Oil/Gas Transmission
  • Sector
  • OLMA Health Care
  • NJR Utilities
  • Exchange
  • OLMA Nasdaq
  • NJR Nasdaq
  • Market Cap
  • OLMA 299.7M
  • NJR 4.5B
  • IPO Year
  • OLMA 2020
  • NJR N/A
  • Fundamental
  • Price
  • OLMA $4.57
  • NJR $45.38
  • Analyst Decision
  • OLMA Strong Buy
  • NJR Hold
  • Analyst Count
  • OLMA 4
  • NJR 6
  • Target Price
  • OLMA $24.50
  • NJR $51.33
  • AVG Volume (30 Days)
  • OLMA 962.9K
  • NJR 636.1K
  • Earning Date
  • OLMA 08-05-2025
  • NJR 08-05-2025
  • Dividend Yield
  • OLMA N/A
  • NJR 3.97%
  • EPS Growth
  • OLMA N/A
  • NJR 63.33
  • EPS
  • OLMA N/A
  • NJR 4.14
  • Revenue
  • OLMA N/A
  • NJR $2,072,804,000.00
  • Revenue This Year
  • OLMA N/A
  • NJR $6.93
  • Revenue Next Year
  • OLMA N/A
  • NJR $2.86
  • P/E Ratio
  • OLMA N/A
  • NJR $10.97
  • Revenue Growth
  • OLMA N/A
  • NJR 20.48
  • 52 Week Low
  • OLMA $2.86
  • NJR $41.68
  • 52 Week High
  • OLMA $16.62
  • NJR $51.95
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 52.70
  • NJR 51.39
  • Support Level
  • OLMA $4.12
  • NJR $44.38
  • Resistance Level
  • OLMA $4.70
  • NJR $45.69
  • Average True Range (ATR)
  • OLMA 0.31
  • NJR 0.61
  • MACD
  • OLMA 0.04
  • NJR 0.18
  • Stochastic Oscillator
  • OLMA 74.73
  • NJR 83.60

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About NJR NewJersey Resources Corporation

New Jersey Resources is an energy services holding company with regulated and nonregulated operations. Its regulated utility, New Jersey Natural Gas, delivers natural gas to nearly 600,000 customers in the state. NJR's nonregulated businesses include investments in commercial solar projects and several large midstream natural gas projects.

Share on Social Networks: